The financial toxicity of cancer: unveiling global burden and risk factors – a systematic review and meta-analysis

Background Cancer, a major global health challenge, not only threatens lives but also imposes severe financial burdens, known as ‘financial toxicity’. This strain extends beyond treatment costs to include indirect expenses like lost income and out-of-pocket payments. Despite its urgency, global insi...

Full description

Saved in:
Bibliographic Details
Main Authors: Addisu Getie, Alemu Birara Zemariam, Befkad Derese Tilahun, Ribka Nigatu Haile, Tegene Atamenta Kitaw, Molla Azmeraw Bizuayehu
Format: Article
Language:English
Published: BMJ Publishing Group 2025-02-01
Series:BMJ Global Health
Online Access:https://gh.bmj.com/content/10/2/e017133.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823858991408611328
author Addisu Getie
Alemu Birara Zemariam
Befkad Derese Tilahun
Ribka Nigatu Haile
Tegene Atamenta Kitaw
Molla Azmeraw Bizuayehu
author_facet Addisu Getie
Alemu Birara Zemariam
Befkad Derese Tilahun
Ribka Nigatu Haile
Tegene Atamenta Kitaw
Molla Azmeraw Bizuayehu
author_sort Addisu Getie
collection DOAJ
description Background Cancer, a major global health challenge, not only threatens lives but also imposes severe financial burdens, known as ‘financial toxicity’. This strain extends beyond treatment costs to include indirect expenses like lost income and out-of-pocket payments. Despite its urgency, global insights remain fragmented, often limited to specific regions with inconsistent findings. This systematic review and meta-analysis aims to provide a comprehensive overview of cancer-related financial toxicity and identify key risk factors contributing to this burden.Methods We conducted a systematic review and meta-analysis, searching databases like Medline, Web of Science, PubMed, Scopus, International Scientific Indexing and Google Scholar for peer-reviewed observational studies. Data were extracted into Microsoft Excel 2021, and study quality was assessed using the Joanna Briggs Institute critical appraisal tool. Statistical analysis was performed using STATA V.17, with catastrophic health expenditures (CHEs) pooled via a random-effects model. Heterogeneity was explored to understand variations in study outcomes. Subgroup and sensitivity analyses were conducted to assess individual study impacts, while publication bias was evaluated using Begger and Egger’s tests. Univariate meta-regression analysis determined the impact of study-level covariates on CHE estimates.Results This analysis included 35 observational studies, covering 428 373 patients with cancer. The pooled prevalence of CHE was 56.1% (95% CI 48.3% to 63.8%). Key risk factors included large family size, low income, lack of health insurance, longer disease duration, older age and multiple treatments. Higher education levels were associated with reduced CHE risk.Conclusion Over half of patients with cancer (56.1%) face catastrophic health expenditures, highlighting a severe financial burden. Addressing this issue requires expanding health insurance, providing financial support and ensuring affordable cancer care. Improving education access can also reduce CHE risk among patients with cancer.
format Article
id doaj-art-7bfb49a3a4394db0910de19fb036fc61
institution Kabale University
issn 2059-7908
language English
publishDate 2025-02-01
publisher BMJ Publishing Group
record_format Article
series BMJ Global Health
spelling doaj-art-7bfb49a3a4394db0910de19fb036fc612025-02-11T09:35:11ZengBMJ Publishing GroupBMJ Global Health2059-79082025-02-0110210.1136/bmjgh-2024-017133The financial toxicity of cancer: unveiling global burden and risk factors – a systematic review and meta-analysisAddisu Getie0Alemu Birara Zemariam1Befkad Derese Tilahun2Ribka Nigatu Haile3Tegene Atamenta Kitaw4Molla Azmeraw Bizuayehu5Department of Nursing, College of Medicine and Health Sciences, Debre Markos University, Debre Markos, EthiopiaDepartment of Nursing, College of Health Science, Woldia University, Woldia, EthiopiaDepartment of Nursing, College of Health Science, Woldia University, Woldia, EthiopiaDepartment of Nursing, College of Health Science, Woldia University, Woldia, EthiopiaDepartment of Nursing, College of Health Science, Woldia University, Woldia, EthiopiaDepartment of Nursing, College of Health Science, Woldia University, Woldia, EthiopiaBackground Cancer, a major global health challenge, not only threatens lives but also imposes severe financial burdens, known as ‘financial toxicity’. This strain extends beyond treatment costs to include indirect expenses like lost income and out-of-pocket payments. Despite its urgency, global insights remain fragmented, often limited to specific regions with inconsistent findings. This systematic review and meta-analysis aims to provide a comprehensive overview of cancer-related financial toxicity and identify key risk factors contributing to this burden.Methods We conducted a systematic review and meta-analysis, searching databases like Medline, Web of Science, PubMed, Scopus, International Scientific Indexing and Google Scholar for peer-reviewed observational studies. Data were extracted into Microsoft Excel 2021, and study quality was assessed using the Joanna Briggs Institute critical appraisal tool. Statistical analysis was performed using STATA V.17, with catastrophic health expenditures (CHEs) pooled via a random-effects model. Heterogeneity was explored to understand variations in study outcomes. Subgroup and sensitivity analyses were conducted to assess individual study impacts, while publication bias was evaluated using Begger and Egger’s tests. Univariate meta-regression analysis determined the impact of study-level covariates on CHE estimates.Results This analysis included 35 observational studies, covering 428 373 patients with cancer. The pooled prevalence of CHE was 56.1% (95% CI 48.3% to 63.8%). Key risk factors included large family size, low income, lack of health insurance, longer disease duration, older age and multiple treatments. Higher education levels were associated with reduced CHE risk.Conclusion Over half of patients with cancer (56.1%) face catastrophic health expenditures, highlighting a severe financial burden. Addressing this issue requires expanding health insurance, providing financial support and ensuring affordable cancer care. Improving education access can also reduce CHE risk among patients with cancer.https://gh.bmj.com/content/10/2/e017133.full
spellingShingle Addisu Getie
Alemu Birara Zemariam
Befkad Derese Tilahun
Ribka Nigatu Haile
Tegene Atamenta Kitaw
Molla Azmeraw Bizuayehu
The financial toxicity of cancer: unveiling global burden and risk factors – a systematic review and meta-analysis
BMJ Global Health
title The financial toxicity of cancer: unveiling global burden and risk factors – a systematic review and meta-analysis
title_full The financial toxicity of cancer: unveiling global burden and risk factors – a systematic review and meta-analysis
title_fullStr The financial toxicity of cancer: unveiling global burden and risk factors – a systematic review and meta-analysis
title_full_unstemmed The financial toxicity of cancer: unveiling global burden and risk factors – a systematic review and meta-analysis
title_short The financial toxicity of cancer: unveiling global burden and risk factors – a systematic review and meta-analysis
title_sort financial toxicity of cancer unveiling global burden and risk factors a systematic review and meta analysis
url https://gh.bmj.com/content/10/2/e017133.full
work_keys_str_mv AT addisugetie thefinancialtoxicityofcancerunveilingglobalburdenandriskfactorsasystematicreviewandmetaanalysis
AT alemubirarazemariam thefinancialtoxicityofcancerunveilingglobalburdenandriskfactorsasystematicreviewandmetaanalysis
AT befkadderesetilahun thefinancialtoxicityofcancerunveilingglobalburdenandriskfactorsasystematicreviewandmetaanalysis
AT ribkanigatuhaile thefinancialtoxicityofcancerunveilingglobalburdenandriskfactorsasystematicreviewandmetaanalysis
AT tegeneatamentakitaw thefinancialtoxicityofcancerunveilingglobalburdenandriskfactorsasystematicreviewandmetaanalysis
AT mollaazmerawbizuayehu thefinancialtoxicityofcancerunveilingglobalburdenandriskfactorsasystematicreviewandmetaanalysis
AT addisugetie financialtoxicityofcancerunveilingglobalburdenandriskfactorsasystematicreviewandmetaanalysis
AT alemubirarazemariam financialtoxicityofcancerunveilingglobalburdenandriskfactorsasystematicreviewandmetaanalysis
AT befkadderesetilahun financialtoxicityofcancerunveilingglobalburdenandriskfactorsasystematicreviewandmetaanalysis
AT ribkanigatuhaile financialtoxicityofcancerunveilingglobalburdenandriskfactorsasystematicreviewandmetaanalysis
AT tegeneatamentakitaw financialtoxicityofcancerunveilingglobalburdenandriskfactorsasystematicreviewandmetaanalysis
AT mollaazmerawbizuayehu financialtoxicityofcancerunveilingglobalburdenandriskfactorsasystematicreviewandmetaanalysis